Up-Regulation of p53/miR-628-3p Pathway, a Novel Mechanism of Shikonin on Inhibiting Proliferation and Inducing Apoptosis of A549 and PC-9 Non–Small Cell Lung Cancer Cell Lines
Shikonin (SHK) is a pleiotropic agent with remarkable cell growth inhibition activity against various cancer types, especially non–small cell lung cancer (NSCLC), but its molecular mechanism is still unclear. Our previous study found that miR-628-3p could inhibit the growth of A549 cells and induce...
Saved in:
Main Authors: | Jieli Pan, Meiya Li, Fenglin Yu, Feiye Zhu, Linyan Wang, Dandan Ning, Xiaoli Hou, Fusheng Jiang |
---|---|
Format: | article |
Language: | EN |
Published: |
Frontiers Media S.A.
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/37f8f2e0ccb14e8dafed70c71211a9dc |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Shikonin Induced Program Cell Death through Generation of Reactive Oxygen Species in Renal Cancer Cells
by: Ming-Feng Tsai, et al.
Published: (2021) -
Deoxyshikonin isolated from Arnebia euchroma inhibits colorectal cancer by down-regulating the PI3K/Akt/mTOR pathway
by: Yuzhen Zhu, et al.
Published: (2019) -
Successful in vivo hyperthermal therapy toward breast cancer by Chinese medicine shikonin-loaded thermosensitive micelle
by: Su Y, et al.
Published: (2017) -
The Cross Talk Between p53 and mTOR Pathways in Response to Physiological and Genotoxic Stresses
by: Danrui Cui, et al.
Published: (2021) -
Role of microRNAs in COVID-19 with implications for therapeutics
by: Nahid Arghiani, et al.
Published: (2021)